PredxBio is a techbio company harnessing the power of spatial biology to unravel the hidden circuitries of the tumor microenvironment and leveraging the most advanced form of AI to get to the “Why?” of cancer with over 90% accuracy. They have successfully established a strong pipeline of customers, including pharmaceutical partners who leverage their solutions to investigate the “reasons” behind varying responses to therapy among patients in their clinical trials.
